Lv11
98 积分 2022-07-12 加入
Two experts and a newbie: [18F]PARPi vs [18F]FTT vs [18F]FPyPARP—a comparison of PARP imaging agents
2天前
已完结
Discovery of high-affinity ligands for prostatic acid phosphatase via DNA-encoded library screening enables targeted cancer therapy
11天前
已完结
Radiolabelled anti-PD-L1 peptide PET/CT in predicting the efficacy of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer
14天前
已完结
Radiolabelled anti-PD-L1 peptide PET/CT in predicting the efficacy of neoadjuvant immunotherapy combined with chemotherapy in resectable non-small cell lung cancer
14天前
已完结
Preclinical and first-in-human evaluation of 18F-labeled D-peptide antagonist for PD-L1 status imaging with PET
18天前
已完结
The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement
18天前
已完结
Preparation and Preliminary Evaluation of a Novel 68Ga-Labeled Linear Peptide PET Probe Targeting Nectin-4
21天前
已完结
Preparation and Preliminary Evaluation of a Novel 68Ga-Labeled Linear Peptide PET Probe Targeting Nectin-4
21天前
已关闭
First-in-Human Study of the Radioligand 68Ga-N188 Targeting Nectin-4 for PET/CT Imaging of Advanced Urothelial Carcinoma
1个月前
已完结
Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy
1个月前
已完结
皖公网安备34019202002308
